Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
β Scribed by Kauff, Noah D.; Satagopan, Jaya M.; Robson, Mark E.; Scheuer, Lauren; Hensley, Martee; Hudis, Clifford A.; Ellis, Nathan A.; Boyd, Jeff; Borgen, Patrick I.; Barakat, Richard R.; Norton, Larry; Castiel, Mercedes; Nafa, Khedoudja; Offit, Kenneth
- Book ID
- 118023721
- Publisher
- Massachusetts Medical Society
- Year
- 2002
- Tongue
- English
- Weight
- 165 KB
- Volume
- 346
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Prophylactic salpingoβoophorectomy (SO), which is recommended in __BRCA1/2__ mutation carriers, still needs to be reappraised. ## METHODS. In all, 89 __BRCA1/BRCA2__ mutation carriers underwent SO between 1994β2004. Past medical and familial history, SO, results and su
Prophylactic Salpingo-Oophorectomy in a Series of 89 Women Carrying a BRCA1 or a BRCA2 Mutation I read with great interest the article published in Cancer by Laki et al. 1 and strongly support that prophylactic salpingo-oophorectomy (SO) is an important option for BRCA1/2 mutation carriers, as asymp
Prophylactic Salpingo-Oophorectomy in a Series of 89 Women Carrying a BRCA1 or a BRCA2 Mutation I read with great interest the article published in Cancer by Laki et al. 1 and strongly support that prophylactic salpingo-oophorectomy (SO) is an important option for BRCA1/2 mutation carriers, as asymp